Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: a post-hoc analysis from the REWIND randomized trial.
Saved in:
| Title: | Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: a post-hoc analysis from the REWIND randomized trial. |
|---|---|
| Authors: | Branch KRH; University of Washington Heart Institute, Seattle, WA, USA., Dagenais GR; Institut Universitaire de Cardiologie et Pneumologie de Québec, Université Laval, Québec City, Québec, Canada., Avezum A; International Research Center, Hospital Alemão Oswaldo Cruz, São Paulo, Brazil., Basile J; Medical University of South Carolina, Ralph H Johnson VA Medical Center, Charleston, SC, USA., Conget I; Endocrinology and Nutrition Department, Hospital Clínic i Universitari, Barcelona, Spain., Cushman WC; University of Tennessee Health Science Center, Memphis, TN, USA., Jansky P; University Hospital Motol, Prague, Czech Republic., Lakshmanan M; Eli Lilly & Co, Indianapolis, IN, USA., Lanas F; Universidad de La Fontera, Temuco, Chile., Leiter LA; Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada., Pais P; St. John's Research Institute, Bangalore, India., Pogosova N; National Medical Research Center of Cardiology, Moscow, Russia., Raubenheimer PJ; Division of Endocrinology, University of Cape Town, Cape Town, South Africa., Ryden L; Department of Medicine K2, Karolinska Institute, Stockholm, Sweden., Shaw JE; Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia., Sheu WHH; Division of Endocrinology and Metabolism, Taipei Veterans General Hospital, Taipei, Taiwan., Temelkova-Kurktschiev T; Robert Koch Medical Center, Sofia, Bulgaria., Bethel MA; Eli Lilly & Co, Indianapolis, IN, USA., Gerstein HC; Population Health Research Institute, Hamilton Health Sciences and McMaster University, Hamilton, Ontario, Canada., Chinthanie R; Population Health Research Institute, Hamilton Health Sciences and McMaster University, Hamilton, Ontario, Canada., Probstfield JL; University of Washington Heart Institute, Seattle, WA, USA. |
| Source: | European journal of heart failure [Eur J Heart Fail] 2022 Oct; Vol. 24 (10), pp. 1805-1812. Date of Electronic Publication: 2022 Sep 20. |
| Publication Type: | Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley Country of Publication: England NLM ID: 100887595 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0844 (Electronic) Linking ISSN: 13889842 NLM ISO Abbreviation: Eur J Heart Fail Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
